[ad_1]
COPENHAGEN, Denmark, Dec. 1, 2025 /PRNewswire/ — Danish diabetes‑tech corporate Hedia is imposing a management exchange efficient 1 December 2025, when Rasmus Kofoed will break in as Leading Government Officer (CEO). He succeeds Lars Christian Lund, who later roughly 2 years within the function has determined to step all the way down to soak up a Workforce CEO place in every other world corporate.
Rasmus Kofoed Appointed CEO of Hedia
Hedia develops virtual answers that assistance population with insulin‑dependent diabetes to raised perceive and govern their remedy via knowledge, synthetic understanding and consumer‑pleasant app era. Based in 2016, the corporate has situated itself as a eminent Ecu participant in virtual diabetes control and virtual therapeutics.
Carl Bilbo, Chairman of the Board of Hedia, commented:
“Under Lars Christian Lund’s leadership, Hedia has progressed from an ambitious start‑up to a professional scale‑up with strong regulatory and commercial development. Lars has played a central role in strengthening the organisation, securing MDR approval and building the foundation for global growth. On behalf of the board I wish to thank him for his outstanding contribution and dedication. We are equally pleased to welcome Rasmus Kofoed as our new CEO. Rasmus brings a strong strategic and commercial profile with proven experience in life science and medtech. He is the right person to lead Hedia into the next phase.”
Rasmus Kofoed brings a cast background within the moment science and medtech industries. He has held senior management positions at Novo Nordisk, Abbott, Roche and Medtronic, and served as CEO of ChemoMetec, with general business and strategic accountability – together with expansion, transformation and world growth. With this sturdy business enjoy, he’s going to think the function as CEO on 1 December 2025, with ambitions to additional beef up Hedia’s product and marketplace platform and amplify the corporate’s world partnerships.
“I see enormous potential in Hedia,” says Rasmus Kofoed.
“The company combines clinical insight with technology in a way that creates real value for people with diabetes. I look forward to working with the team to extend our reach, strengthen our partnerships and continue the journey to make Hedia a leading player in digital diabetes care.”
With this management transition, Hedia marks the after herbal step in its expansion walk and reaffirms its loyalty to increasing its world footprint and business engagement.
Web site: www.hedia.com
Picture – https://mma.prnewswire.com/media/2833717/Rasmus_Kofoed.jpg
Brand – https://mma.prnewswire.com/media/2833716/Hedia_logo.jpg
[ad_2]
Source link
